Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines

Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Clinical and Experimental Metastasis (Impact Factor: 3.49). 03/2011; 28(5):437-49. DOI: 10.1007/s10585-011-9382-z
Source: PubMed

ABSTRACT Gli1 is an established oncogene and its expression in Estrogen Receptor (ER) α negative and triple negative breast cancers is predictive of a poor prognosis; however, the biological functions regulated by Gli1 in breast cancer have not been extensively evaluated. Herein, Gli1 was over-expressed or down-regulated (by RNA interference and by expression of the repressor form of Gli3) in the ERα negative, human breast cancer cell lines MDA-MB-231 and SUM1315. Reduced expression of Gli1 in these two cell lines resulted in a decrease in migration and invasion. Gli1 over-expression increased the migration and invasion of MDA-MB-231 cells with a corresponding increase in expression of MMP-11. Silencing MMP-11 in MDA-MB-231 cells that over-expressed Gli1 abrogated the Gli1-induced enhancement of migration and invasion. Sustained suppression of Gli1 expression decreased growth of MDA-MB-231 in vitro by increasing apoptosis and decreasing proliferation. In addition, silencing of Gli1 reduced the numbers and sizes of pulmonary metastases of MDA-MB-231 in an in vivo experimental metastasis assay. In summary, Gli1 promotes the growth, survival, migration, invasion and metastasis of ERα negative breast cancer. Additionally, MMP-11 is up-regulated by Gli1 and mediates the migration and invasion induced by Gli1 in MDA-MB-231.

Electronic supplementary material
The online version of this article (doi:10.1007/s10585-011-9382-z) contains supplementary material, which is available to authorized users.

Download full-text


Available from: Danny R Welch, Sep 28, 2015
35 Reads
  • Source
    • "Gli1 over-expression has been shown to increase the migration and invasiveness of these cell lines. In summary, Gli1 promotes the growth, survival, migration, invasion and metastasis of ERα-negative breast cancer (Kwon et al., 2011). Recent advances in the treatment of breast cancer and early detection caused increases in survival rates. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this review, we describe the patterns of known immunological components in breast milk and examine the relationship between breastfeeding and reduced risk of breast cancer. The top risk factors for breast cancer are a woman's age and family history, specifically having a first-degree relative with breast cancer. Women that have a history of breastfeeding have been shown to have reduced rates of breast cancer. Although the specific cause has not been elucidated, previous studies have suggested that breastfeeding reduces the risk of breast cancer primarily through two mechanisms: the differentiation of breast tissue and reduction in the lifetime number of ovulatory cycles. In this context, one of the primary components of human milk that is postulated to affect cancer risk is alpha-lactalbumin. Tumour cell death can be induced by HAMLET (a human milk complex of alpha-lactalbumin and oleic acid). HAMLET induces apoptosis only in tumour cells, while normal differentiated cells are resistant to its effects. Therefore, HAMLET may provide safe and effective protection against the development of breast cancer. Mothers should be encouraged to breastfeed their babies because the complex components of human milk secretion make it an ideal food source for babies and clinical evidence has shown that there is a lower risk of breast cancer in women who breastfed their babies.
    Asian Pacific journal of cancer prevention: APJCP 11/2012; 13(11):5327-32. DOI:10.7314/APJCP.2012.13.11.5327 · 2.51 Impact Factor
  • Source
    • "Several mesenchymal genes such as cadherin N are induced (Figure 5). Matrix Metalloproteinase 11 (MMP-11) is up-regulated by Gli signalling and facilitates EMT-associated invasion [49]. Wnt pathway is also induced by up-regulation of Wnt5A [48]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Epithelial to Mesenchymal transition (EMT) in cancer, a process permitting cancer cells to become mobile and metastatic, has a signaling hardwire forged from development. Multiple signaling pathways that regulate carcinogenesis enabling characteristics in neoplastic cells such as proliferation, resistance to apoptosis and angiogenesis are also the main players in EMT. These pathways, as almost all cellular processes, are in their turn regulated by ubiquitination and the Ubiquitin-Proteasome System (UPS). Ubiquitination is the covalent link of target proteins with the small protein ubiquitin and serves as a signal to target protein degradation by the proteasome or to other outcomes such as endocytosis, degradation by the lysosome or specification of cellular localization. This paper reviews signal transduction pathways regulating EMT and being regulated by ubiquitination.
    Journal of Biomedical Science 07/2012; 19(1):67. DOI:10.1186/1423-0127-19-67 · 2.76 Impact Factor
  • Source
Show more